95 related articles for article (PubMed ID: 14565505)
1. Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs.
Komazin G; Ptak RG; Emmer BT; Townsend LB; Drach JC
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1725-7. PubMed ID: 14565505
[No Abstract] [Full Text] [Related]
2. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):811-8. PubMed ID: 9057868
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):802-10. PubMed ID: 9057867
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Gudmundsson KS; Drach JC; Wotring LL; Townsend LB
J Med Chem; 1997 Feb; 40(5):785-93. PubMed ID: 9057865
[TBL] [Abstract][Full Text] [Related]
6. Studies designed to increase the stability and antiviral activity (HCMV) of the active benzimidazole nucleoside, TCRB.
Townsend LB; Gudmundsson KS; Daluge SM; Chen JJ; Zhu Z; Koszalka GW; Boyd L; Chamberlain SD; Freeman GA; Biron KK; Drach JC
Nucleosides Nucleotides; 1999; 18(4-5):509-19. PubMed ID: 10432642
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
Chan JH; Chamberlain SD; Biron KK; Davis MG; Harvey RJ; Selleseth DW; Dornsife RE; Dark EH; Frick LW; Townsend LB; Drach JC; Koszalka GW
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):101-23. PubMed ID: 10772705
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Kawashima E; Freeman GA; Koszalka GW; Drach JC; Townsend LB
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):125-53. PubMed ID: 10772706
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir.
Chou S
Rev Med Virol; 2008; 18(4):233-46. PubMed ID: 18383425
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.
Chou S; Wechel LC; Marousek GI
J Infect Dis; 2007 Jul; 196(1):91-4. PubMed ID: 17538888
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral evaluation of polyhalogenated imidazole nucleosides: dimensional analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Chien TC; Saluja SS; Drach JC; Townsend LB
J Med Chem; 2004 Nov; 47(23):5743-52. PubMed ID: 15509173
[TBL] [Abstract][Full Text] [Related]
12. Susceptibilities of human cytomegalovirus clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosides.
Hwang JS; Schilf R; Drach JC; Townsend LB; Bogner E
Antimicrob Agents Chemother; 2009 Dec; 53(12):5095-101. PubMed ID: 19786605
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole 2'-isonucleosides: design, synthesis, and antiviral activity of 2-substituted-5,6-dichlorobenzimidazole 2'-isonucleosides.
Freeman GA; Selleseth DW; Rideout JL; Harvey RJ
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):155-74. PubMed ID: 10772707
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles.
Migawa MT; Girardet JL; Walker JA; Koszalka GW; Chamberlain SD; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1242-51. PubMed ID: 9575044
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues.
Papadakis G; Gerasi M; Snoeck R; Marakos P; Andrei G; Lougiakis N; Pouli N
Molecules; 2020 Oct; 25(19):. PubMed ID: 33022923
[TBL] [Abstract][Full Text] [Related]
16. Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.
Selleseth DW; Talarico CL; Miller T; Lutz MW; Biron KK; Harvey RJ
Antimicrob Agents Chemother; 2003 Apr; 47(4):1468-71. PubMed ID: 12654696
[TBL] [Abstract][Full Text] [Related]
17. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
Avery RK; Marty FM; Strasfeld L; Lee I; Arrieta A; Chou S; Tatarowicz W; Villano S
Transpl Infect Dis; 2010 Dec; 12(6):489-96. PubMed ID: 20682012
[TBL] [Abstract][Full Text] [Related]
18. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter.
Song X; Vig BS; Lorenzi PL; Drach JC; Townsend LB; Amidon GL
J Med Chem; 2005 Feb; 48(4):1274-7. PubMed ID: 15715497
[TBL] [Abstract][Full Text] [Related]
19. Tetrahalogenated benzimidazole D-ribonucleosides are active against rat cytomegalovirus.
Dittmer A; Woskobojnik I; Adfeldt R; Drach JC; Townsend LB; Voigt S; Bogner E
Antiviral Res; 2017 Jan; 137():102-107. PubMed ID: 27871886
[TBL] [Abstract][Full Text] [Related]
20. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
